BridgeBio Pharma, Inc. (BBIO)

81.05 -0.45 (-0.55%) USD  |  NASDAQ  |  Aug 24, 16:00
80.04 -1.01 (-1.25%) After-Hours: 20:00
More

BridgeBio Pharma Shareholders Equity (Quarterly) : -2.515B for June 30, 2026

Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -2.515B
March 31, 2026 -2.278B
December 31, 2025 -2.087B
September 30, 2025 -1.933B
June 30, 2025 -1.788B
March 31, 2025 -1.648B
December 31, 2024 -1.468B
September 30, 2024 -1.230B
June 30, 2024 -1.093B
March 31, 2024 -1.050B
December 31, 2023 -1.354B
September 30, 2023 -1.208B
June 30, 2023 -1.362B
March 31, 2023 -1.226B
December 31, 2022 -1.255B
September 30, 2022 -1.138B
Date Value
June 30, 2022 -1.026B
March 31, 2022 -1.041B
December 31, 2021 -870.41M
September 30, 2021 -743.40M
June 30, 2021 -464.29M
March 31, 2021 -395.29M
December 31, 2020 57.91M
September 30, 2020 163.76M
June 30, 2020 265.76M
March 31, 2020 380.72M
December 31, 2019 408.45M
September 30, 2019 459.76M
June 30, 2019 -316.12M
March 31, 2019 -226.90M
December 31, 2018 -163.99M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 1.354B
Ionis Pharmaceuticals, Inc. 439.74M
Pfizer Inc. 85.19B
Vertex Pharmaceuticals, Inc. 20.25B
BioMarin Pharmaceutical, Inc. 6.322B

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 1.217B
Total Liabilities (Quarterly) 3.723B
Debt to Equity Ratio -1.353
Current Ratio 1.227
Net Debt Paydown Yield -1.44%